Amgen stock rebounded Wednesday, shaking off "overdone" fears that its monthly weight-loss shot causes excessive bone mineral ...

On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair and CEO Dave Ricks ... but my ...

The California biotech has drawn partnerships with Eli Lilly and J&J on the promise of its approach to rebalancing the immune ...

TRexBio secured $84 million Series B funding, led by Delos Capital with Eli Lilly and Johnson & Johnson participating, to ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

Monday’s edition of Forbes Daily covers fresh records for S&P 500 and bitcoin, gambling in the UAE, Musk surpasses $300B, open questions for H-1B visa holders and more.

Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate for if given a role in the incoming Trump ...

Shares of Nvidia rallied to a record high on Thursday, making the chipmaker the first company in history to surpass a stock ...

Trump’s social media company, Trump Media and Technology Group, rose by 6 percent, beating an already hot market. This jump ...

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

Post-approval safety issues arose for a third of novel drugs approved from 2001 through 2010, leading a small number to be ...

Hims & Hers Health will report third-quarter financial results after the market close on Monday. Analysts expect the company to report earnings of 4 cents per share and revenue of $382.2 million, ...